Company page

20/20 Biolabs, Inc.

20/20 Biolabs, Inc. is a public company traded under the ticker AIDX in the American market, with a market capitalization of approximately $6.97 million. The company focuses on biolabs and related services. Its operations are aimed at advancing innovations in the biotechnology sector.

profileAIDX:NASDAQAI content: aiUpdated June 24, 2026/company/2020-biolabs-inc-common-stock/c-gbxtwypn
20/20 Biolabs, Inc. logo
Ticker
AIDX:NASDAQ
Asset type
Stock
Market cap
$7.0M
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
NASDAQ
Currency
USD